期刊文献+

用沙丁胺醇和溴化异丙托品治疗慢阻肺的效果分析 被引量:1

下载PDF
导出
摘要 目的 :探讨用沙丁胺醇和溴化异丙托品治疗慢阻肺的临床效果。方法 :对近年来我院收治的40例慢阻肺患者的临床资料进行回顾性研究。我们根据用药方案的不同将这40例患者分为常规组与实验组,每组各有20例患者。我院对常规组患者进行常规治疗,对实验组患者在进行常规治疗的基础上,使用沙丁胺醇和溴化异丙托品进行治疗。治疗结束后,比较两组患者的FEV1%(一秒钟用力呼气量与用力肺活量的比值)、PEFR(呼气高峰流量)和Pa O2(动脉血氧分压)。结果 :经治疗,实验组患者的FEV1%、PEFR和Pa O2均明显高于常规组患者,组间比较差异有统计学意义(P<0.05)。结论 :用沙丁胺醇和溴化异丙托品治疗慢阻肺的临床效果显著,可有效地改善患者的临床症状。此疗法值得在临床上推广应用。
作者 夏月平
机构地区 河北大学医学部
出处 《当代医药论丛》 2016年第17期115-116,共2页
  • 相关文献

参考文献4

二级参考文献40

  • 1赵红梅,毛毅敏.急性加重期慢性阻塞性肺疾病28例治疗体会[J].郑州大学学报(医学版),2007,42(4):788-789. 被引量:6
  • 2Sturton RG, Trifilieff A, Nicholson AG, et al. Pharmacological char- acterization of indacaterol, a novel once daily inhaled 132 adrenocep-tor agonist, on small airways in human and rat precision-cut lung slices [ J ]. J Pharmacol Exp Ther,2008,324,70 - 75.
  • 3Barrett V J, Morrison V, Sturton RG, et al. Pharmacological character- isation of GW642444, a long-acting 132-agonist ( LABA ) with rapid onset and long duration,on isolated large and small human airways [J]. Am J Respir Crit Care Med,2010,181 ,A4453.
  • 4Hanania H, Feldman G, Zachgo W, et al. Dose-related efficacy of vilanterol trifenatate in COPD [ J ]. Eur Respir J, 2010,36,217 - 221.
  • 5Bouyssou T, Casarosa P, Naline E, et al. Pharmacological character- ization of Olodaterol, a ovel Inhaled 132 adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models [ J ]. J Phar- macol Exp Ther,2010,334,53 - 62.
  • 6VanNoord JA, Smeets JJ, Drenth BM, et al. 24-hour bronchodilation following a single dose of the novel 132-agonist olodaterol in COPD [ J ]. Pulm Pharmacol Ther,2011,24,666 - 672.
  • 7Mason KP, Zgleszewski S, Forman RE, et al. An Exaggerated hyper- tensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine [ J ]. Anesth Analg, 2009, 108 : 906 - 908.
  • 8Sentellas S, Ramos I, Alberti J, et al. Aclidinium bromide, a new, long-acting,inhaled muscarinic antagonist:in vitro plasma inactiva- tion and pharmacological activity of its main metabolites [ J ]. Eur J Pharm Sci ,2010,39:283 - 290.
  • 9Page CP. Doxofylline:A "Novofylline" [ J]. Pulm Pharmacolo Ther, 2010,23,231 -234.
  • 10Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long-acting bronchodilators: two randomized clinical trials [ J]. Lancet ,2009,374:695 - 703.

共引文献47

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部